Dino Bekric
7PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 14, 2026
The Role of Prognostic Clinical-Pathological, (Immuno-) Histological, and Molecular Parameters in Pseudomyxoma Peritonei Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Systematic Review and Meta-Analysis.Jan Philipp Ramspott, Anna Kolmhofer, Lukas Schabl-Cayron
|Apr 11, 2024
The efficacy of ferroptosis-inducing compounds IKE and RSL3 correlates with the expression of ferroptotic pathway regulators CD71 and SLC7A11 in biliary tract cancer cells.Dino Bekric, Tobias Kiesslich, Matthias Ocker
|Jun 30, 2023
Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cells.Christian Mayr, Tobias Kiesslich, Dino Bekric
|Mar 11, 2023
Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer.Dino Bekric, Daniel Neureiter, Celina Ablinger
|Apr 12, 2022
Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation.Dino Bekric, Matthias Ocker, Christian Mayr
|Aug 07, 2021
HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer.Christian Mayr, Tobias Kiesslich, Sara Erber
Pageof 2
Frequent Collaborators
6 joint publications
Markus Ritter
4 joint publications
Daniel Neureiter
3 joint publications
Martin Jakab
2 joint publications
Tarkan Jäger
2 joint publications
Matthias Ocker
2 joint publications
Christian Mayr
1 joint publications
Martin Gaisberger
1 joint publications
Martin Pichler
1 joint publications
Sebastian Stintzing
1 joint publications
Johannes Bischof
